These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6235402)

  • 21. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
    Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
    G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
    [No Abstract]   [Full Text] [Related]  

  • 22. Thymopentin in dermatology.
    Haneke E
    Curr Probl Dermatol; 1989; 18():283-9. PubMed ID: 2663371
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
    Faist E; Riedel A; Bolla K
    Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of thymopentin in the therapy of recurrent oral ulcers].
    Robotti MP; Fabbri G; Baldin C; Faccioli G; Ciaffoni S
    Minerva Stomatol; 1988 Jun; 37(6):497-503. PubMed ID: 3050443
    [No Abstract]   [Full Text] [Related]  

  • 25. [Correction of lipid peroxidation in stress with the peptide bioregulator thymopentin].
    Deviatkina TA; Brechko VV; Tarasenko LM; Zviago'lskaia IN; Bezuglyĭ IuV; Rituma IR; Klusha VE
    Fiziol Zh (1978); 1989; 35(5):14-8. PubMed ID: 2687033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome.
    Silvestris F; Gernone A; Frassanito MA; Dammacco F
    J Lab Clin Med; 1989 Feb; 113(2):139-44. PubMed ID: 2644387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
    Franchimont P; Hauwaert C; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymopentin administration and increase of sero-conversion after B-hepatitis vaccine in diabetic patients.
    Pagani S; Cruciani L; Chianelli M; Procaccini E; Pozzilli P
    Diabetes Res; 1989 Dec; 12(4):199-201. PubMed ID: 2534655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymopentin treatment in a patient with pluriorificial pyoderma vegetans.
    Simon M; Djawari D; Horstein OP; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():125-8. PubMed ID: 3898284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Possible selective effects of thymopentin on polymorphonuclear activity in patients undergoing dialysis].
    Salvati F
    Recenti Prog Med; 1989 Sep; 80(9):499. PubMed ID: 2687987
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunostimulation by TP-5 in immunocompromised patients and animals--current status of investigation.
    Waymack JP; Alexander JW
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):225-32. PubMed ID: 3539496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of thymopentin in the treatment of post-radiation cystitis].
    Martinoli F; Catania G; Bertana F; Caldera G
    Minerva Urol Nefrol; 1988; 40(4):275-6. PubMed ID: 3075095
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
    Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
    Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymopentin in chronic Trichophyton rubrum infection.
    Molin L; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulation in infection caused by human immunodeficiency virus.
    Phair JP
    J Lab Clin Med; 1989 Feb; 113(2):135-6. PubMed ID: 2644386
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of two new immunomodulators on normal and burn injury neutrophils and macrophages.
    Waymack JP; Miskell P; Gonce SJ; Alexander JW
    J Burn Care Rehabil; 1987; 8(1):9-14. PubMed ID: 3553203
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
    Cantore M; Bucalossi A; Butini P; Carnevali A; Cavion MA; Leoncini L
    G Clin Med; 1989; 70(6-7):421, 423, 425. PubMed ID: 2670653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymopentin in the treatment of juvenile chronic arthritis.
    Bardare M; Corona F; Ogliari MT; Cohen E
    Clin Exp Rheumatol; 1990; 8(1):89-93. PubMed ID: 1971780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of recurrent oral aphthae with thymopoetin pentapeptide].
    Djawari D; Haneke E
    Hautarzt; 1983 Sep; 34(9):463-4. PubMed ID: 6355012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunologic and cytologic aspects of Hashimoto's thyroiditis during therapy with thymopentin].
    Aiello A; Cristofaro M; Carrozza F; Di Rienzo G; Carile L
    Clin Ter; 1990 May; 133(4):227-31. PubMed ID: 2142910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.